Qin et al. reply

[1]  S. Taylor-Robinson,et al.  Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[2]  Beiwen Zheng,et al.  Alterations of the human gut microbiome in liver cirrhosis , 2014, Nature.

[3]  P. Marcellin,et al.  Diabetes mellitus is an independent prognostic factor for major liver‐related outcomes in patients with cirrhosis and chronic hepatitis C , 2014, Hepatology.

[4]  Andmorgan R. Fisher,et al.  Altered profile of human gut microbiome is associated with cirrhosis and its complications. , 2014, Journal of hepatology.

[5]  Zhigang Zhang,et al.  Large-Scale Survey of Gut Microbiota Associated With MHE Via 16S rRNA-Based Pyrosequencing , 2013, The American Journal of Gastroenterology.

[6]  Mathieu Almeida,et al.  Dietary intervention impact on gut microbial gene richness , 2013, Nature.

[7]  Fredrik H. Karlsson,et al.  Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.

[8]  Andmorgan R. Fisher,et al.  Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy , 2013, PloS one.

[9]  Masoumeh Sikaroodi,et al.  Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[10]  S. Taylor-Robinson,et al.  A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy , 2012, Metabolic Brain Disease.

[11]  P. Hylemon,et al.  Linkage of gut microbiome with cognition in hepatic encephalopathy. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[12]  F. Bushman,et al.  Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.

[13]  Baoli Zhu,et al.  Characterization of fecal microbial communities in patients with liver cirrhosis , 2011, Hepatology.

[14]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[15]  A. Keshavarzian,et al.  Quantitative Assessment of the Human Gut Microbiome Using Multitag Pyrosequencing , 2010, Chemistry & biodiversity.

[16]  S. Akimoto,et al.  Gastric acid reduction leads to an alteration in lower intestinal microflora. , 2009, Biochemical and biophysical research communications.

[17]  N. Chavez-Tapia,et al.  Use and overuse of proton pump inhibitors in cirrhotic patients. , 2008, Medical science monitor : international medical journal of experimental and clinical research.

[18]  A. B. Sukhomlinov,et al.  [Liver cirrhosis]. , 1989, Fel'dsher i akusherka.